Figure 7.Tumor mutational burden and GSEA analysis in risk subgroups. (A, B) Somatic mutation landscape analysis in the risk subgroup. (C, D) GSEA analysis of risk subgroups.
Figure 7 — Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma | Aging
